Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

MDGL

Rankning i aktier #1943
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical... Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
Aktiekurs
$469.52
Marknadsvärde
$10.85B
Förändring (1 dag)
5.02%
Förändring (1 år)
6.72%
Land
US
Handel Madrigal Pharmaceuticals, Inc. (MDGL)

Kategori

Healthcare
Historik för aktiesplit för Madrigal Pharmaceuticals, Inc. (MDGL)
Aktien Madrigal Pharmaceuticals, Inc. (symbol: MDGL) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Jul 25, 2016.
En MDGL-aktie köpt före Jul 25, 2016 motsvarar nu 0.028571428571429 MDGL-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2016-07-25 1:35 x0.028571428571429 x0.028571428571429
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL